title: Adjuvant mitotane for adrenocortical cancer--working through uncertainty.
authors.affiliation: Department of Clinical and Biological Sciences, Internal Medicine I, University ofTurin, Orbassano 10043, Italy. terzolo@usa.net
authors.forename: M
authors.initials: M
authors.lastname: Terzolo
authors.forename: M
authors.initials: M
authors.lastname: Fassnacht
authors.forename: G
authors.initials: G
authors.lastname: Ciccone
authors.forename: B
authors.initials: B
authors.lastname: Allolio
authors.forename: A
authors.initials: A
authors.lastname: Berruti
mesh_terms: D000306:Adrenal Cortex Neoplasms / Q000188:drug therapy* / Q000473:pathology; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy* / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008939:Mitotane / Q000008:administration & dosage / Q000627:therapeutic use*; D012008:Recurrence; D035501:Uncertainty
chemical_list: D018931:Antineoplastic Agents, Hormonal; D008939:Mitotane